Treatment with a choline kinase inhibitor prompts immune cells to clear away damaged mitochondria, thus reducing NLRP3 inflammasome activation and preventing inflammation
Inflammation is a balanced physiological response – the body needs it to eliminate invasive organisms and foreign irritants, but excessive inflammation can harm healthy cells, contributing to aging and chronic diseases. To help keep tabs on inflammation, immune cells employ a molecular machine called the NLRP3 inflammasome. NLRP3 is inactive in a healthy cell, but is switched “on” when the cell’s mitochondria (energy-generating organelles) are damaged by stress or exposure to bacterial toxins.
However, when the NLRP3 inflammasome gets stuck in the “on” position, it can contribute to a number of chronic inflammatory conditions, including gout, osteoarthritis, fatty liver disease and Alzheimer’s and Parkinson’s diseases. In a new mouse study, researchers at University of California San Diego School of Medicine discovered a unique approach that might help treat some chronic inflammatory diseases: force cells to eliminate damaged mitochondria before they activate the NLRP3 inflammasome.
The study, published April 11, 2019 by Cell Metabolism, was led by senior author Michael Karin, PhD, Distinguished Professor of Pharmacology and Pathology and Ben and Wanda Hildyard Chair for Mitochondrial and Metabolic Diseases at UC San Diego School of Medicine, and first author Elsa Sanchez-Lopez, PhD, a senior postdoctoral researcher in Karin’s lab.
In a 2018 study published in Nature, Karin’s team had shown that damaged mitochondria activate the NLRP3 inflammasome. The researchers also found that the NLRP3 inflammasome is de-activated when mitochondria are removed by the cell’s internal waste recycling process, called mitophagy.
“After that, we wondered if we could reduce harmful excess inflammation by intentionally inducing mitophagy, which would eliminate damaged mitochondria and should in turn pre-emptively inhibit NLRP3 inflammasome activation,” Karin said. “But at the time we didn’t have a good way to induce mitophagy.”
More recently, Sanchez-Lopez was studying how macrophages regulate their uptake of choline, a nutrient critical for metabolism, when she discovered something that can initiate mitophagy: an inhibitor of the enzyme choline kinase (ChoK). With ChoK inhibited, choline is no longer incorporated into mitochondrial membranes. As a result, the cells perceive the mitochondria as damaged, and cleared them away by mitophagy.
“Most importantly, by getting rid of damaged mitochondria with ChoK inhibitors, we were finally able to inhibit NLRP3 inflammasome activation,” Karin said.
To test their new ability to control NLRP3 inflammasome in a living system, the researchers turned to mice. They discovered that treatment with ChoK inhibitors prevented acute inflammation caused by uric acid (accumulation of which triggers gout flares) and a bacterial toxin.
By several measures, ChoK inhibitor treatment also reversed chronic inflammation associated with a genetic disease called Muckle-Well Syndrome, which is caused by mutations in NLRP3 genes. One such measure is spleen size – the larger the spleen, the more inflammation. The spleens of Muckle-Well Syndrome mice are on average twice as large as normal mice, but their spleen sizes normalized after ChoK inhibitor treatment.
NLRP3 inflammasome promotes inflammation because it triggers the release of two very potent pro-inflammatory molecules called cytokines: interleukin (IL)-1? and IL-18. According to Karin, there are existing drugs that can block IL-1?, but not IL-18. ChoK inhibitors, his team found, can reduce both cytokines.
“There are several diseases, including lupus and osteoarthritis, whose treatment will likely require dual inhibition of both IL-1? and IL-18,” Karin said.
Learn more: In Mice, Eliminating Damaged Mitochondria Alleviates Chronic Inflammatory Disease
The Latest on: Chronic inflammatory disease
[google_news title=”” keyword=”chronic inflammatory disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Chronic inflammatory disease
- ‘Don’t give up hope’: FIT Physical Therapy promotes healing for life with chronic pain programon April 27, 2024 at 8:03 am
Did you know that over 50 million people nationwide (about 20% of adults) suffer from chronic pain? America has a pain crisis, and it’s only getting worse. Enter the skilled and caring experts at FIT ...
- The Reason Why Kidney Diseases And Kidney Failures Are More Common In Black Sub-Saharan Africanson April 27, 2024 at 4:36 am
WHY KIDNEY DISEASES ARE MORE COMMON IN BLACKS Compared to the white population, blacks are more than 3 times as likely to have kidney failure .
- Irregular bone marrow cells may increase heart disease riskon April 26, 2024 at 4:00 am
Over time, bone marrow stem cells develop key genetic errors and pass them on to immune cells. This may increase the risk of developing heart disease.
- I’m a periodontist, here’s how I avoid gum disease (and why I skip mouthwash)on April 26, 2024 at 2:10 am
Over half of the British public have signs of gum disease. Gingivitis, a painful inflammation of the gums, is a precursor to periodontal disease [bacterial infection of the gums and teeth] which can ...
- AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in studyon April 25, 2024 at 7:26 am
AbbVie said on Thursday its drug, Rinvoq, for treating a type of inflammatory skin condition was found to be more effective than Regeneron Pharmaceuticals and Sanofi's Dupixent in a late-stage head-to ...
- Single-cell analysis reveals mechanisms of a common complication of Crohn's diseaseon April 24, 2024 at 8:00 am
Mount Sinai researchers have published the first study to use single-cell analysis in identifying several pathophysiological mechanisms of abnormal passageways in the digestive system known as ...
- What You Need To Know about Crohn's Disease Poopon April 24, 2024 at 2:30 am
Crohn's disease can affect the appearance and smell of your poop. It can also cause changes in your bowel movements, like how often you need to poop.
- Gut bacteria and inflammatory bowel disease: Exploring the potential of prebioticson April 22, 2024 at 1:38 pm
A growing body of research suggests that manipulating gut bacteria may offer a promising approach to managing inflammatory bowel disease (IBD), a chronic and debilitating condition affecting millions ...
- Cruciferous vegetables may offer new hope for inflammatory bowel disease managementon April 21, 2024 at 7:59 pm
Study evaluates the role of cruciferous vegetables and their bioactive components in mitigating inflammatory bowel disease through in vitro, in vivo, and preliminary clinical investigations, ...
- Pelvic Inflammatory Disease: 9 Unusual Signs Your Reproductive System Has Been Compromised By Sexually Transmitted Diseaseson April 18, 2024 at 12:22 am
Pelvic Inflammatory Disease (PID) is a concerning infection quite common among women. It's a deep infection in the female reproductive system and is often the result of untreated sexually transmitted ...
via Bing News